Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The gene GNE encodes a bifunctional enzyme, UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Its mutations are found in distal myopathy with rimmed vacuoles (DMRV) and hereditary inclusion body myopathy (HIBM). Those disorders are characterized clinically by predominant anterior tibial muscle weakness and atrophy, and pathologically by rimmed vacuoles on muscle biopsy. We analyzed 11 Korean patients with GNE mutations. The mutations showed ethnic similarity to those of Japanese patients, showing the highest frequency with V572L. Another mutation of C13S was also found recurring in our patient group. Interestingly, about half of the patients showed limb-girdle myopathy rather than distal myopathy. This was further represented by limb muscle CT scans revealing atrophic hamstring and relatively spared anterior tibial muscle. However, quadriceps muscles were consistently spared both in distal and limb-girdle phenotypes. In conclusion, this study demonstrates a phenotypic diversity associated with GNE mutations. Recognizing a wider clinical spectrum of GNE mutations will help benefit more patients with imminent new therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2012.07.061DOI Listing

Publication Analysis

Top Keywords

gne mutations
16
associated gne
8
distal myopathy
8
rimmed vacuoles
8
anterior tibial
8
tibial muscle
8
mutations
6
patients
5
myopathy
5
gne
5

Similar Publications

ATP13A2 is an endolysosomal polyamine transporter mutated in several neurodegenerative conditions involving lysosomal defects, including Parkinson's disease (PD). While polyamines are polybasic and polycationic molecules that play pleiotropic cellular roles, their specific impact on lysosomal health is unknown. Here, we demonstrate lysosomal polyamine accumulation in ATP13A2 knockout (KO) cell lines and human induced pluripotent stem cell (iPSC)-derived neurons.

View Article and Find Full Text PDF

[ gene-related thrombocytopenia: a case report and literature review].

Zhongguo Dang Dai Er Ke Za Zhi

June 2025

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Objectives: To study the clinical characteristics and treatment outcomes of gene-related thrombocytopenia.

Methods: A retrospective analysis was conducted on the data of one child with gene-related thrombocytopenia, along with a review of cases reported in the literature, focusing on clinical phenotypes and treatment characteristics.

Results: Among 31 patients, the onset was primarily in the neonatal period or early childhood, characterized by mucocutaneous bleeding.

View Article and Find Full Text PDF

Effects of a homozygous missense mutation in the gene p.V543M on cell phenotype and its mechanisms.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

January 2025

Department of Clinical Laboratory, Third Xiangya Hospital, Central South University, Changsha 410013, China.

Objectives: Uridine diphospho-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) myopathy is a progressive neurodegenerative disease associated with homozygous or compound heterozygous missense mutations in the gene. This study aims to explore the impact of the homozygous p.V543M mutation in on cell phenotype and to gain preliminary insights into the underlying mechanisms.

View Article and Find Full Text PDF

Background: GNE myopathy is a muscle disease due to mutations in the GNE gene, encoding for the key enzyme of sialic acid biosynthesis. This disorder firstly involves distal lower limb muscles and slowly progresses to scapular girdle and distal upper limb muscles.

Patients/methods: We describe a cohort of 13 patients (9/13 women and 4/13 men) affected by GNE myopathy, followed on average for 15 years.

View Article and Find Full Text PDF

Expression of GNE mutant proteins increases CHO intracellular CMP-Neu5Ac levels without impact on bioprocess performance.

Bioprocess Biosyst Eng

August 2025

BioMedicine Design, Preclinical and Translational Sciences, Pfizer Research and Development, 610 Main Street, Cambridge, MA, 02139, USA.

Modulation of various nucleotide sugar levels in cells has been demonstrated as an effective way to alter the composition of N-glycans. Previous studies have demonstrated the ability to impact CMP-Neu5Ac levels by the addition of N-acetylated mannosamine (ManNAc) to culture media. In this study, the relationship between adding varying levels of ManNAc to cell cultures and the impact on both CMP-Neu5Ac levels and cell growth were examined.

View Article and Find Full Text PDF